Copay Assistance Programs Threatened By Medicaid Best Price Rule – PhRMA Lawsuit

The regulatory provisions being challenged are part of a Trump-era “midnight rule” that could be changed by the Biden Administration before implementation, but PhRMA is not taking any chances about the future of copay assistance programs.

Copay Accumulator Programs Not Obvious To Patients At Pharmacy Counter

The Pharmaceutical Research and Manufacturers of America is asking a federal court to revoke the provisions of a recent Medicaid rule that would require manufacturers to include the value of copay assistance in calculations of Medicaid “best prices” unless they can prove that all the assistance goes to patients and not in part to health plans.

The requirement is part of a broader rule issued by the Centers for Medicare and Medicaid Services 31 December...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet